In mid-February 2017, India’s National Pharmaceutical Pricing Authority (NPAA) fixed the price of drug eluting stents at $450 and bare metal stents at $110 USD. The NPAA may look to regulate the prices of 14 other medical devices that also have high price markups. These devices range from artificial heart valves to consumables such as catheters and syringes. The NPAA has requested medical device manufacturers to track and log details about costs associated with production. The NPAA has stated that they intend to continue to deal with the high cost of medical devices. Despite these price control efforts in India, some medical devices are sold at prices that yield huge profits to the manufacturers.